Skip to main content

Advertisement

Table 2 Distribution of multidrug–resistance among isolates of colonized patients

From: Influx of multidrug-resistant organisms by country-to-country transfer of patients

Species No. (%) of isolates No. (%) of MDR–GN No. (%) XDR–GN No. and type of Carbapenemase in XDR–GN
Escherichia coli 42 (40.4) 39 (65) 3 (21.4) 1 none
1 NDM–1
1 KPC
MRSA 18 (17.3) N/A N/A N/A
Klebsiella pneumoniae 18 (17.3) 14 (23.3) 4 (28.6) 2 none
1 NDM–1
1 OXA–48
VRE (all E. faecium) 12 (11.5) N/A N/A N/A
Pseudomonas aeruginosa 6 (5.8) 3 (5) 3 (21.4) 2 none
1 VIM–1
Acinetobacter baumanii 3 (2.9) 0 (0) 3 (21.4) 3 OXA–23
Enterobacter cloacae 3 (2.9) 2 (3.3) 1 (7.1) 1 VIM–4
Proteus mirabilis 1 (1.0) 1 (1.7) 0 (0) N/A
Klebsiella oxytoca 1 (1.0) 1 (1.7) 0 (0) N/A
total 104 (100) 60 (100) 14 (100) 9
  1. N/A not applicable, MRSA methicillin–resistant Staphylococcus aureus, VRE vancomycin–resistant Enterococci, NDM–1 New Delhi metallo–beta–lactamase 1, KPC Klebsiella pneumoniae carbapenemase, OXA–23/48 oxacillinase group beta–lactamase 23/48, VIM–1/4 Verona integron–encoded metallo–beta–lactamase 1/4